Carotuximab (TRC105) is a IgG1 моноклональный антитело that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions.
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.